The Impact of Polypharmacy on Elderly Patients and Strategies to Reduce Risks
Keywords:
Polypharmacy, Elderly Patients, Medication Management, Risk Reduction, Adverse Drug ReactionsAbstract
Polypharmacy, the concurrent use of multiple medications, is increasingly prevalent among elderly patients, posing significant risks to their health and well-being. This paper explores the multifaceted impact of polypharmacy, highlighting its contribution to adverse drug reactions (ADRs), cognitive decline, hospitalizations, and decreased quality of life. Through a comprehensive review of existing literature and data analysis, the paper identifies key risk factors associated with polypharmacy in elderly populations. It further proposes evidence-based strategies to mitigate these risks, including medication review programs, deprescribing initiatives, and patient- centered care models. Case studies and statistical insights illustrate the practical application of these strategies, underscoring the critical role of healthcare providers in managing polypharmacy. The findings emphasize the importance of collaborative efforts among physicians, pharmacists, and patients to optimize medication regimens, reduce unnecessary prescriptions, and enhance patient outcomes. Future research directions are discussed to address existing gaps and foster the development of innovative approaches for minimizing polypharmacy-related risks in aging populations.
Downloads
Metrics
References
Li X, Ma D, Feng Z, Gao M, Dong P, Shi Y, et al. Preferences of patients with multiple chronic diseases for medication in rural areas of an Eastern Province China: a discrete choice experiment. Frontiers in Medicine 2024;11:1439136.
Unlu O, Levitan EB, Reshetnyak E, Kneifati-Hayek J, Diaz I, Archambault A, et al. Polypharmacy in Older Adults Hospitalized for Heart Failure. Circ: Heart Failure 2020;13:e006977. https://doi.org/10.1161/CIRCHEARTFAILURE.120.006977.
Hajat C, Stein E. The global burden of multiple chronic conditions: a narrative review. Preventive Medicine Reports 2018;12:284–93.
Wong CW. Medication-related problems in older people: how to optimise medication management. Hong Kong Medical Journal 2020;26:510.
Simonson W, Feinberg JL. Medication-Related Problems in the Elderly: Defining the Issues and Identifying Solutions. Drugs & Aging 2005;22:559–69. https://doi.org/10.2165/00002512-200522070-00002.
Molokhia M, Majeed A. Current and future perspectives on the management of polypharmacy. BMC Fam Pract 2017;18:70. https://doi.org/10.1186/s12875-017-0642-0.
Khezrian M, McNeil CJ, Murray AD, Myint PK. An overview of prevalence, determinants and health outcomes of polypharmacy. Therapeutic Advances in Drug Safety 2020;11:2042098620933741. https://doi.org/10.1177/2042098620933741.
Wastesson JW, Morin L, Tan ECK, Johnell K. An update on the clinical consequences of polypharmacy in older adults: a narrative review. Expert Opinion on Drug Safety 2018;17:1185–96. https://doi.org/10.1080/14740338.2018.1546841.
Cooper RE, Hanratty É, Morant N, Moncrieff J. Mental health professionals’ views and experiences of antipsychotic reduction and discontinuation. PLoS One 2019;14:e0218711.
Corsonello A, Pedone C, Incalzi RA. Age-related pharmacokinetic and pharmacodynamic changes and related risk of adverse drug reactions. Current Medicinal Chemistry 2010;17:571–84.
Sera LC, McPherson ML. Pharmacokinetics and pharmacodynamic changes associated with aging and implications for drug therapy. Clinics in Geriatric Medicine 2012;28:273–86.
Shi S, Klotz U. Age-related changes in pharmacokinetics. Current Drug Metabolism 2011;12:601–10.
Drenth‐van Maanen AC, Wilting I, Jansen PAF. Prescribing medicines to older people—How to consider the impact of ageing on human organ and body functions. Brit J Clinical Pharma 2020;86:1921–30. https://doi.org/10.1111/bcp.14094.
Reis Da Silva TH. Pharmacokinetics in older people: an overview of prescribing practice. Journal of Prescribing Practice 2024;6:374–81. https://doi.org/10.12968/jprp.2024.6.9.374.
Gorgaslidze N, Sulashvili N. THE SCIENTIFIC DISCUSSION OF PECULIARITIES OF VARIOUS AGES PHARMACOTHERAPY-FEATURES OF TREATMENT IN DIFFERENT AGES, SIDE EFFECTS OF MEDICINES AND ITS PHARMACOECONOMIC CHARACTERIZATIONS ASPECT n.d.
Houglum JE, Harrelson GL, Seefeldt TM. Pharmacodynamic Principles: Mechanism of Drug Action and Therapeutic Considerations. Principles of Pharmacology for Athletic Trainers, Routledge; 2024, p. 36–59.
Denfeld QE, Turrise S, MacLaughlin EJ, Chang P-S, Clair WK, Lewis EF, et al. Preventing and Managing Falls in Adults With Cardiovascular Disease: A Scientific Statement From the American Heart Association. Circ: Cardiovascular Quality and Outcomes 2022;15. https://doi.org/10.1161/HCQ.0000000000000108.
Garrison SR, Schweinert SA, Boyer MW, Singh M, Vadapalli S, Engelmann JM, et al. Polypharmacy and pharmacogenomics in high-acuity behavioral health care for autism spectrum disorder: A retrospective study 2025.
McGraw C, Drennan V. Older people and medication management: from compliance to concordance. Reviews in Clinical Gerontology 2004;14:145–53.
Bulut EA, Isik AT. Abuse/misuse of prescription medications in older adults. Clinics in Geriatric Medicine 2022;38:85–97.
Duerden M, Avery T, Payne R. Polypharmacy and medicines optimisation. Making It Safe and Sound London: The King’s Fund 2013.
Burton LC, Anderson GF, Kues IW. Using Electronic Health Records to Help Coordinate Care. Milbank Quarterly 2004;82:457–81. https://doi.org/10.1111/j.0887-378X.2004.00318.x.
Al Hamid A, Ghaleb M, Aljadhey H, Aslanpour Z. A systematic review of hospitalization resulting from medicine‐related problems in adult patients. Brit J Clinical Pharma 2014;78:202–17. https://doi.org/10.1111/bcp.12293.
Ballantyne PJ, Mirza RM, Austin Z, Boon HS, Fisher JE. Becoming old as a ‘pharmaceutical person’: negotiation of health and medicines among ethnoculturally diverse older adults. Canadian Journal on Aging/La Revue Canadienne Du Vieillissement 2011;30:169–84.
Mair A. Medication safety in polypharmacy: technical report 2019.
Nunes V, Neilson J, O’flynn N, Calvert N, Kuntze S, Smithson H, et al. Clinical guidelines and evidence review for medicines adherence: involving patients in decisions about prescribed medicines and supporting adherence. London: National Collaborating Centre for Primary Care and Royal College of General Practitioners 2009;364.
Loganathan M, Singh S, Franklin BD, Bottle A, Majeed A. Interventions to optimise prescribing in care homes: systematic review. Age and Ageing 2011;40:150–62.
Akyon SH, Akyon FC, Yılmaz TE. Artificial intelligence-supported web application design and development for reducing polypharmacy side effects and supporting rational drug use in geriatric patients. Frontiers in Medicine 2023;10:1029198.
Muth C, Blom JW, Smith SM, Johnell K, Gonzalez‐Gonzalez AI, Nguyen TS, et al. Evidence supporting the best clinical management of patients with multimorbidity and polypharmacy: a systematic guideline review and expert consensus. J Intern Med 2019;285:272–88. https://doi.org/10.1111/joim.12842.
Anthierens S, Tansens A, Petrovic M, Christiaens T. Qualitative insights into general practitioners views on polypharmacy. BMC Fam Pract 2010;11:65. https://doi.org/10.1186/1471-2296-11-65.
Reinhard SC, Given B, Petlick NH, Bemis A. Supporting family caregivers in providing care. Patient Safety and Quality: An Evidence-Based Handbook for Nurses 2008.
Azmi LF, Ahmad N. Exploring the Influence of Human-Centered Design on User Experience in Health Informatics Sector: A Systematic Review. In: Saeed F, Mohammed F, Al-Nahari A, editors. Innovative Systems for Intelligent Health Informatics, vol. 72, Cham: Springer International Publishing; 2021, p. 242–51. https://doi.org/10.1007/978-3-030-70713-2_24.
Tsou AY, Creutzfeldt CJ, Gordon JM. The good doctor: professionalism in the 21st century. Handbook of Clinical Neurology 2013;118:119–32.
Tantray J, Patel A, Wani SN, Kosey S, Prajapati BG. Prescription Precision: A Comprehensive Review of Intelligent Prescription Systems. CPD 2024;30:2671–84. https://doi.org/10.2174/0113816128321623240719104337.
Horsky J, Schiff GD, Johnston D, Mercincavage L, Bell D, Middleton B. Interface design principles for usable decision support: a targeted review of best practices for clinical prescribing interventions. Journal of Biomedical Informatics 2012;45:1202–16.
Wang X, Liu K, Shirai K, Tang C, Hu Y, Wang Y, et al. Prevalence and trends of polypharmacy in U.S. adults, 1999–2018. Glob Health Res Policy 2023;8:25. https://doi.org/10.1186/s41256-023-00311-4.
Products - Data Briefs - Number 347 - August 2019 2019. https://www.cdc.gov/nchs/products/databriefs/db347.htm (accessed February 3, 2025).
Delara M, Murray L, Jafari B, Bahji A, Goodarzi Z, Kirkham J, et al. Prevalence and factors associated with polypharmacy: a systematic review and meta-analysis. BMC Geriatrics 2022;22:601. https://doi.org/10.1186/s12877-022-03279-x.
Mehta RS, Kochar BD, Kennelty K, Ernst ME, Chan AT. Emerging approaches to polypharmacy among older adults. Nature Aging 2021;1:347–56.
Pazan F, Wehling M. Polypharmacy in older adults: a narrative review of definitions, epidemiology and consequences. Eur Geriatr Med 2021;12:443–52. https://doi.org/10.1007/s41999-021-00479-3.
Morin L, Johnell K, Laroche M-L, Fastbom J, Wastesson JW. The epidemiology of polypharmacy in older adults: register-based prospective cohort study. CLEP 2018;Volume 10:289–98. https://doi.org/10.2147/CLEP.S153458.
Hilmer S, Gnjidic D. The Effects of Polypharmacy in Older Adults. Clin Pharmacol Ther 2009;85:86–8. https://doi.org/10.1038/clpt.2008.224.
Mukete BN, Ferdinand KC. Polypharmacy in Older Adults With Hypertension: A Comprehensive Review. J of Clinical Hypertension 2016;18:10–8. https://doi.org/10.1111/jch.12624.
Rahman MM. Sample size determination for survey research and non-probability sampling techniques: A review and set of recommendations. Journal of Entrepreneurship, Business and Economics 2023;11:42–62.
Doss W, Rayfield J, Burris S, Lawver D. A quantitative content analysis of survey research methods over a 40-year time period in the Journal of Agricultural Education. Journal of Agricultural Education 2021;62:310–28.
Harrison R, Jones B, Gardner P, Lawton R. Quality assessment with diverse studies (QuADS): an appraisal tool for methodological and reporting quality in systematic reviews of mixed- or multi-method studies. BMC Health Serv Res 2021;21:144. https://doi.org/10.1186/s12913-021-06122-y.
Mishra SB, Alok S. Handbook of research methodology 2022.
Kurczewska-Michalak M, Lewek P, Jankowska-Polańska B, Giardini A, Granata N, Maffoni M, et al. Polypharmacy management in the older adults: a scoping review of available interventions. Frontiers in Pharmacology 2021;12:734045.
Kunneman M, Branda ME, Ridgeway JL, Tiedje K, May CR, Linzer M, et al. Making sense of diabetes medication decisions: a mixed methods cluster randomized trial using a conversation aid intervention. Endocrine 2022;75:377–91. https://doi.org/10.1007/s12020-021-02861-4.
Dautzenberg L, Bretagne L, Koek HL, Tsokani S, Zevgiti S, Rodondi N, et al. Medication review interventions to reduce hospital readmissions in older people. J American Geriatrics Society 2021;69:1646–58. https://doi.org/10.1111/jgs.17041.
Whitman A, Erdeljac P, Jones C, Pillarella N, Nightingale G. Managing Polypharmacy in Older Adults with Cancer Across Different Healthcare Settings. DHPS 2021;Volume 13:101–16. https://doi.org/10.2147/DHPS.S255893.
Wang J, Shen JY, Yu F, Nathan K, Caprio TV, Conwell Y, et al. How to deprescribe potentially inappropriate medications during the hospital-to-home transition: stakeholder perspectives on essential tasks. Clinical Therapeutics 2023;45:947–56.
Masnoon N, Lo S, Hilmer S. A stewardship program to facilitate anticholinergic and sedative medication deprescribing using the drug burden index in electronic medical records. Brit J Clinical Pharma 2023;89:687–98. https://doi.org/10.1111/bcp.15517.
Mouazer A, Tsopra R, Sedki K, Letord C, Lamy J-B. Decision-support systems for managing polypharmacy in the elderly: A scoping review. Journal of Biomedical Informatics 2022;130:104074.
Farcher R, Graber SM, Boes S, Huber CA. Are integrated care models associated with improved drug safety in Swiss primary care? an observational analysis using healthcare claims data. Plos One 2024;19:e0311099.
Kumar RS. Pharmacotherapy and the Critical Role of Pharmacists in Rehabilitation Medicine. Pharmacotherapy 2024;1.
Bieri M, Del Río Carral M, Santiago-Delefosse M, Miano G, Rosset F, Verloo H, et al. Beliefs about Polypharmacy among home-dwelling older adults living with multiple chronic conditions, informal Caregivers and healthcare professionals: A qualitative study. Healthcare, vol. 9, MDPI; 2021, p. 1204.
Garland CT, Guénette L, Kröger E, Carmichael P-H, Rouleau R, Sirois C. A new care model reduces polypharmacy and potentially inappropriate medications in long-term care. Journal of the American Medical Directors Association 2021;22:141–7.
Rodrigues AR, Teixeira-Lemos E, Mascarenhas-Melo F, Lemos LP, Bell V. Pharmacist Intervention in Portuguese Older Adult Care. Healthcare, vol. 10, MDPI; 2022, p. 1833.
Keller MS, Qureshi N, Mays AM, Sarkisian CA, Pevnick JM. Cumulative Update of a Systematic Overview Evaluating Interventions Addressing Polypharmacy. JAMA Netw Open 2024;7:e2350963. https://doi.org/10.1001/jamanetworkopen.2023.50963.
Mangin D, Lamarche L, Templeton JA, Salerno J, Siu H, Trimble J, et al. Theoretical Underpinnings of a Model to Reduce Polypharmacy and Its Negative Health Effects: Introducing the Team Approach to Polypharmacy Evaluation and Reduction (TAPER). Drugs Aging 2023;40:857–68. https://doi.org/10.1007/s40266-023-01055-z.
Daunt R, Curtin D, O’Mahony D. Polypharmacy stewardship: a novel approach to tackle a major public health crisis. The Lancet Healthy Longevity 2023;4:e228–35.
Mangin D, Lamarche L, Agarwal G, Ali A, Cassels A, Colwill K, et al. Team approach to polypharmacy evaluation and reduction: feasibility randomized trial of a structured clinical pathway to reduce polypharmacy. Pilot Feasibility Stud 2023;9:84. https://doi.org/10.1186/s40814-023-01315-0.
Mangin D, Lamarche L, Agarwal G, Banh HL, Dore Brown N, Cassels A, et al. Team approach to polypharmacy evaluation and reduction: study protocol for a randomized controlled trial. Trials 2021;22:746. https://doi.org/10.1186/s13063-021-05685-9.
Poorcheraghi H, Valieiny N, Pashaeypoor S, Mirzadeh FS. Polypharmacy Management Strategies in Older Adults; A scoping review. IJNR 2022;17. https://doi.org/10.22034/ijnr.17.5.71.
Díez R, Cadenas R, Susperregui J, Sahagún AM, Fernández N, García JJ, et al. Drug-related problems and polypharmacy in nursing home residents: a cross-sectional study. International Journal of Environmental Research and Public Health 2022;19:4313.
Sharma M, Loh KP, Nightingale G, Mohile SG, Holmes HM. Polypharmacy and potentially inappropriate medication use in geriatric oncology. Journal of Geriatric Oncology 2016;7:346–53.
Setiati S, Harimurti K, Fitriana I, Dwimartutie N, Istanti R, Azwar MK, et al. Co-occurrence of frailty, possible sarcopenia, and malnutrition in community-dwelling older outpatients: a multicentre observational study. Annals of Geriatric Medicine and Research 2024.
Alsallal M, Alsubaiei N, Assiri E, Amireh A, Booth A, Kofi M. Effectiveness and Cost Effectiveness of Pharmacist-led Deprescribing Interventions in Nursing Homes and Ambulatory Care Settings in Elderly Patients: A Systematic Review. J Family Med Prim Care Open Acc 2022;6:170.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 ashwini dale, Girish Kashid
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
